chalcone has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegro, D; Boumendjel, A; Boutonnat, J; Champelovier, P; Derouazi, M; McLeer-Florin, A; Muhammad, D; Peyrot, V; Souard, F; Toussaint, B | 1 |
| Abiko, Y; Akihisa, T; Kimura, Y; Motani, K; Nagai, H; Okano, S; Shibata, Y; Suzuki, T; Tabata, K | 1 |
2 other study(ies) available for chalcone and Brain Neoplasms
| Article | Year |
|---|---|
A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chalcone; Chalcones; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Microtubules; Proto-Oncogene Proteins c-bcr; Rats | 2009 |
Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma.
Topics: Angelica; Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Chalcone; Down-Regulation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Fluorescent Dyes; Humans; Neoplasm Proteins; Neuroblastoma; Plant Stems; Proteomics; Reactive Oxygen Species; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Subcellular Fractions; Tetrazolium Salts; Thiazoles | 2008 |